| Filed On | Filing |
|---|---|
| 12 Nov 2026 |
Form 4: Tobin James R, Director
Sold 4,059 shares ($385K) |
| 09 Nov 2026 | 144 |
| 05 Nov 2026 | 10-Q |
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition
Strong Revenue Generation Drives Increase in Full-Year 2026 Guidance; Recent Progress Positions Company for Continued Growth with Several Near- and Mid-Term Catalysts |
| 30 Oct 2026 |
Form 4: Araujo Fernando N., See Remarks
Received 22,969 shares as a grant or award · Granted 34,419 Stock Option (Right to Buy) |
| 29 Sep 2026 |
Form 3: Araujo Fernando N., See Remarks
No securities owned |
| 14 Sep 2026 |
Form 4: Weill David, Director
Bought 1,336 shares ($109K) |
| 10 Sep 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
Andover, Mass. – September 10, 2026 – TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), the global leader in portable warm perfusion for donor organs for transplantation, today announced the appointment of Fernando Araujo as Chief ... |
| 17 Aug 2026 |
Form 4: Tobin James R, Director
Gave 18,000 shares as a gift |
| 04 Aug 2026 | 10-Q |
| 04 Aug 2026 |
8-K: Results of Operations and Financial Condition
Andover, Mass. – August 4, 2026 – TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today report... |
| 14 Jul 2026 |
Form 4: Corcoran Nicholas, See remarks
Received 11,727 shares as a grant or award · Granted 17,784 Stock Option (Right to Buy) |
| 14 Jul 2026 |
Form 4: Hernandez Gerardo, Chief Financial Officer
Received 17,246 shares as a grant or award · Granted 26,153 Stock Option (Right to Buy) |
| 14 Jul 2026 |
Form 4: Hassanein Waleed H, Director
Received 49,669 shares as a grant or award · Granted 112,984 Stock Option (Right to Buy) |
| 17 Jun 2026 |
Form 4: Gunderson Thomas J., Director
Received 19,285 shares by exercise or conversion ($42.6K) · Sold 9,624 shares ($722K) |
| 15 Jun 2026 | 144 |
| 29 May 2026 | SD |
| 22 May 2026 |
Form 4: Lovell Stephanie, Director
Received 2,922 shares as a grant or award |
| 22 May 2026 |
Form 4: Weill David, Director
Received 2,922 shares as a grant or award |
| 22 May 2026 |
Form 4: Raines Merilee, Director
Received 2,922 shares as a grant or award |
Loading...